Skip to content

A Randomized Controlled Trial of Risk Assessment Score Combined with Fluorescence Angiography of Anastomosis in Predicting Anastomotic leakage after Anterior Resection for Rectal Cancer

A Randomized Controlled Trial of Risk Assessment Score Combined with Fluorescence Angiography of Anastomosis in Predicting Anastomotic leakage after Anterior Resection for Rectal Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011616
Enrollment
Unknown
Registered
2017-06-10
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

Anastomotic fluorescein angiography group:Preventive stoma
Non-staining group:Preventive stoma

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 80 years old; 2) pathologically confirmed rectal adenocarcinoma (including high school differentiation of tubular adenocarcinoma, papillary adenocarcinoma, poorly differentiated tubular adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma); 3) newly diagnosed chest resorcine examination of the lower edge of the tumor from the anal margin of 16cm within the patient; 4) preoperative patients with albumin <28g; or hemoglobin <8g except; 5) no other multiple primary cancer; 6) have adequate organ function; 7) Patient or family member who is able to understand the research program and is willing to participate in this study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) combined with severe intestinal obstruction or intestinal perforation and other patients requiring emergency surgical resection; 2) previous history of colorectal surgery, may affect the digestive tract reconstruction of patients; 3) need to combine organ resection; 4) ASA * IV or V; 5) pregnant or lactating women; 6) serious mental illness; 7) severe emphysema, interstitial pneumonia or ischemic heart disease can not tolerate surgery; 8) continuous systemic steroid therapy within 1 month; 9) patients or their families can not understand the conditions and objectives of this study; 10) has a history of adverse reactions or ICG, iodine or iodine dyes known to be allergic to patients failed.

Design outcomes

Primary

MeasureTime frame
Postoperative anastomotic leakage rate;

Countries

China

Contacts

Public ContactZhong Ming

Renji Hospital, Shanghai Jiao Tong University School of Medicine

drzhongm@126.com+86 13003152950

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026